Efficacy of Bushen Huoxue Decoction for Patients with Intra Uterine Adhesions After Trans Cervical Resection Adhesions Operation and Effect on Fibrotic Factors
Clinic|更新时间:2021-03-05
|
Efficacy of Bushen Huoxue Decoction for Patients with Intra Uterine Adhesions After Trans Cervical Resection Adhesions Operation and Effect on Fibrotic Factors
Chinese Journal of Experimental Traditional Medical FormulaeVol. 27, Issue 6, Pages: 62-68(2021)
MA Ben-ling,ZHANG Xiao-hong,LI Lin,et al.Efficacy of Bushen Huoxue Decoction for Patients with Intra Uterine Adhesions After Trans Cervical Resection Adhesions Operation and Effect on Fibrotic Factors[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(06):62-68.
MA Ben-ling,ZHANG Xiao-hong,LI Lin,et al.Efficacy of Bushen Huoxue Decoction for Patients with Intra Uterine Adhesions After Trans Cervical Resection Adhesions Operation and Effect on Fibrotic Factors[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(06):62-68. DOI: 10.13422/j.cnki.syfjx.20210324.
Efficacy of Bushen Huoxue Decoction for Patients with Intra Uterine Adhesions After Trans Cervical Resection Adhesions Operation and Effect on Fibrotic Factors
To discuss the efficacy of Bushen Huoxue decoction for recovery in patients with intra uterine adhesions (IUA) after trans cervical resection adhesions (TCRA) operation, and to investigate its effect on fibrosis factor.
Method
2
The 110 patients were randomly divided into two groups by random number table (55 cases for control group and 55 cases for observation group). The patients in both groups got TCRA, and after the operation, they got estradiol valerate tablets+progesterone capsules. The patients in control group additionally got Jinfengwan before meals, 10 g/time, 2 times/day. Patients in observation additionally got syndrome differentiation and treatment by Bushen Huoxuetang, 1 dose/day. The treatment course was 3 months in both groups, and 6 months' follow-up was recorded. Before and after treatment, menstrual volume, period and cycle were recorded. During the follow-up, pregnancy, ectopic pregnancy and abortion were also recorded. Endoscopy and vagina color Doppler ultrasound were conducted to detect endometrial thickness, uterine volume, resistance index (RI), pulsation index (PI) and blood flow index (FI). Scores of IUA and syndrome of kidney deficiency and blood stasis were graded. At the 6
th
months after treatment, rate of intrauterine re-adhesion was recorded. Levels of transforming growth factor-
β
1
(TGF-
β
1
), connective tissue growth factor (CTGF), matrix metalloproteinase inhibitor-1 (TIMP-1), platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1) and matrix metalloproteinase-9 (MMP-9) were detected, and safety was evaluated.
Result
2
Total effective rate of clinical efficacy was 96.36% (53/55) in observation group, higher than 83.64% (46/55) in control group (
χ
2
=4.959,
P
<
0.05). Recovery rate of menstrual volume, period and cycle were 92.73% (51/55), 90.91% (50/55), and 94.55% (52/55) in observation group, higher than 72.73% (40/55), 76.36% (42/55), and 76.36% (42/55) in control group(
χ
2
=7.698,
χ
2
=4.245,
χ
2
=7.313,
P
<
0.05,
P
<
0.01). During the follow-up, rate of intrauterine re-adhesions was 23.64% (13/55) in observation group, lower than 43.64% (24/55) in control group (
χ
2
=4.927,
P
<
0.05). Pregnancy rate was 45.45% (25/55), higher than 25.45% (14/55) in control group(
χ
2
=4.807,
P
<
0.05). Score of syndrome of kidney deficiency and blood stasis and IUA scores in observation group were lower than those in control group (
P
<
0.01). Endometrial thickness, uterine volume, and FI were higher than those in control group (
P
<
0.01). Levels of RI, PI, TGF-
β
1
, CTGF, PDGF, IGF-1 and TIMP-1 were lower than those in control group (
P
<
0.01), while level of MMP-9 was higher than that in control group (
P
<
0.01). No adverse reactions related to traditional Chinese medicine were found.
Conclusion
2
Bushen Huoxue decoction can promote the recovery of menstruation, increase the thickness of endometrium, improve the blood circulation of uterus, regulate the expression of fibrogenic factors
in vivo
, prevent and treat intrauterine adhesions, reduce the rate of intrauterine re-adhesions, and improve the rate of pregnancy, with a good comprehensive effect and high safety for clinical use.
COCCIA M E , BECATTINI C , BRACCO G L , et al . Pressure lavage under ultrasound guidance: a new approach for outpatient treatment of intrauterine adhesions [J]. Fertil Steril , 2001 , 75 ( 3 ): 601 - 606 .
ZHU H Y , GE T X , PAN Y B , et al . Advanced role of hippo signaling in endometrial fibrosis: implications for intrauterine adhesion [J]. Chin Med J (Engl) , 2017 , 130 ( 22 ): 2732 - 2737 .
SALMA U , XUE M , ALI SHEIKH M S , et al . Role of transforming growth factor- β 1 and Smads signaling pathway in intrauterine adhesion [J]. Mediators Inflamm , 2016 , 2016 : 4158287 .
LI J , DU S , SHENG X , et al . microRNA-29b inhibits endometrial fibrosis by regulating the Sp1-TGF- β 1 /Smad-CTGF axis in a rat model [J]. Reprod Sci , 2016 , 23 ( 3 ): 386 - 394 .
WANG X , BAO H , LIU X , et al . Effects of endometrial stem cell transplantation combined with estrogen in the repair of endometrial injury [J]. Oncol Lett , 2018 , 16 ( 1 ): 1115 - 1122 .
ZHENG S X , WANG J , WANG X L , et al . Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells [J]. Int J Mol Med , 2018 , 41 ( 4 ): 2201 - 2212 .
BAYHAN Z , ZEREN S , KOCAK F E , et al . Antiadhesive and anti-inflammatory effects of pirfenidone in postoperative intra-abdominal adhesion in an experimental rat model [J]. J Surg Res , 2016 , 201 ( 2 ): 348 - 355 .